000293813 001__ 293813
000293813 005__ 20241217140438.0
000293813 0247_ $$2doi$$a10.1080/14796694.2024.2402639
000293813 0247_ $$2pmid$$apmid:39345094
000293813 0247_ $$2ISSN$$a1479-6694
000293813 0247_ $$2ISSN$$a1744-8301
000293813 037__ $$aDKFZ-2024-01971
000293813 041__ $$aEnglish
000293813 082__ $$a610
000293813 1001_ $$aLeypoldt, Lisa B$$b0
000293813 245__ $$aPlain language summary of isatuximab plus carfilzomib, lenalidomide, and dexamethasone for the treatment of people with high-risk newly diagnosed multiple myeloma.
000293813 260__ $$aLondon$$bFuture Medicine Ltd$$c2024
000293813 3367_ $$2DRIVER$$aarticle
000293813 3367_ $$2DataCite$$aOutput Types/Journal article
000293813 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1734440642_5827
000293813 3367_ $$2BibTeX$$aARTICLE
000293813 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000293813 3367_ $$00$$2EndNote$$aJournal Article
000293813 500__ $$a2024 Dec;20(39):3193-3207
000293813 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000293813 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000293813 650_7 $$2Other$$aclinical trial
000293813 650_7 $$2Other$$ahigh-risk
000293813 650_7 $$2Other$$aisatuximab
000293813 650_7 $$2Other$$amultiple myeloma (MM)
000293813 650_7 $$2Other$$aplain language summary
000293813 7001_ $$0P:(DE-He78)2ef631585610340ff425c9c31fcabd03$$aTichy, Diana$$b1$$udkfz
000293813 7001_ $$aBesemer, Britta$$b2
000293813 7001_ $$aHanel, Mathias$$b3
000293813 7001_ $$aRaab, Marc S$$b4
000293813 7001_ $$aMann, Christoph$$b5
000293813 7001_ $$aMunder, Markus$$b6
000293813 7001_ $$0P:(DE-HGF)0$$aReinhardt, Hans Christian$$b7
000293813 7001_ $$aNogai, Axel$$b8
000293813 7001_ $$aGorner, Martin$$b9
000293813 7001_ $$aKo, Yon-Dschun$$b10
000293813 7001_ $$aWit, Maike de$$b11
000293813 7001_ $$aSalwender, Hans$$b12
000293813 7001_ $$aScheid, Christof$$b13
000293813 7001_ $$aGraeven, Ullrich$$b14
000293813 7001_ $$aPeceny, Rudolf$$b15
000293813 7001_ $$aStaib, Peter$$b16
000293813 7001_ $$aDieing, Annette$$b17
000293813 7001_ $$aEinsele, Hermann$$b18
000293813 7001_ $$aJauch, Anna$$b19
000293813 7001_ $$aHundemer, Michael$$b20
000293813 7001_ $$aZago, Manola$$b21
000293813 7001_ $$0P:(DE-He78)3cd8a9939d0a75acabca280ecc5ff77a$$aPozek, Ema$$b22$$udkfz
000293813 7001_ $$0P:(DE-He78)e15dfa1260625c69d6690a197392a994$$aBenner, Axel$$b23$$udkfz
000293813 7001_ $$aBokemeyer, Carsten$$b24
000293813 7001_ $$aGoldschmidt, Hartmut$$b25
000293813 7001_ $$aWeisel, Katja C$$b26
000293813 773__ $$0PERI:(DE-600)2184533-5$$a10.1080/14796694.2024.2402639$$gp. 1 - 15$$n39$$p3193-3207$$tFuture oncology$$v20$$x1479-6694$$y2024
000293813 909CO $$ooai:inrepo02.dkfz.de:293813$$pVDB
000293813 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2ef631585610340ff425c9c31fcabd03$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000293813 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000293813 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)3cd8a9939d0a75acabca280ecc5ff77a$$aDeutsches Krebsforschungszentrum$$b22$$kDKFZ
000293813 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e15dfa1260625c69d6690a197392a994$$aDeutsches Krebsforschungszentrum$$b23$$kDKFZ
000293813 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000293813 9141_ $$y2024
000293813 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-25
000293813 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-25
000293813 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-25
000293813 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-25
000293813 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-25
000293813 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-25
000293813 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-25
000293813 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-10-25
000293813 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFUTURE ONCOL : 2022$$d2023-10-25
000293813 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-10-25
000293813 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lC060 Biostatistik$$x0
000293813 9201_ $$0I:(DE-He78)ED01-20160331$$kED01$$lDKTK Koordinierungsstelle Essen/Düsseldorf$$x1
000293813 980__ $$ajournal
000293813 980__ $$aVDB
000293813 980__ $$aI:(DE-He78)C060-20160331
000293813 980__ $$aI:(DE-He78)ED01-20160331
000293813 980__ $$aUNRESTRICTED